Approvals/TGA/KARVEZIDE 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

Approved

STANDARD

KARVEZIDE 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: acb384af63724498
Product Name: KARVEZIDE 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack
Artg Id: 101833
Artg Name: KARVEZIDE 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2005-05-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-05159-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-05158-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

acb384af63724498

Type

Standard